Researchers in the field of exposomics explain how cutting-edge technologies are unlocking this biological archive, ushering in a new era of disease prevention and personalized medicine.

NEW YORK – In cell and gene therapies, the genetic machinery is key to producing the proteins missing or dysregulated in a disease, but whether the therapeutic cassette reaches target cells and how ...

A joint research team has developed a modular protein adapter technology that enables the stable attachment of various ...

Hathway’s technology uses natural epigenetic processes to dial gene activity up or down, rather than rewriting the genetic ...

With a new raise provided by Flagship Pioneering, the new company is aiming to find “the silent window” before disease symptoms set in.

By understanding a patient’s unique genetic profile, biomarker readings and lifestyle information, doctors could tailor the ...

Chronic fatigue, particularly in the context of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and post-viral syndromes, represents a growing ...

BPGbio, Inc., a leading biology-first, AI-powered clinical-stage biopharma company focused on mitochondrial biology and protein homeostasis, today announced the presentation of seven presentations at ...

GenAI offers a realistic path forward in tackling previously undruggable targets, with the potential to reshape the entire ...

For patients with disorders such as autism and schizophrenia, mutations in the same gene could require different treatments, according to new research from Yale School of Medicine (YSM).

Researchers have developed engineered human microglia that detect disease-related brain changes and release therapeutic ...